Sanofi Pasteur, TIV + H1N1, Pediatric Population
Condition:   InfluenzaInterventions:   Biological: Trivalent Inactivated Influenza Vaccine;   Biological: Inactivated H1N1 VaccineSponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified December 2010 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2009 Category: Research Source Type: clinical trials

Peds Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels
Condition:   InfluenzaIntervention:   Biological: Influenza Virus Vaccine, Monovalent A/H1N1 A/California/7/2009 NYMC X-179ASponsor:   National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified March 2010 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2009 Category: Research Source Type: clinical trials

A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Children
Condition:   Influenza Caused by the Novel Influenza A (H1N1) VirusInterventions:   Biological: CSL425;   Biological: CSL425Sponsor:   CSL LimitedCompleted - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2009 Category: Research Source Type: clinical trials